Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034069 (
pulmonary fibrosis
)
7,050
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Epimorphin
was originally identified as a mesenchymal, cell surface-associated protein that modulates epithelial morphogenesis in embryonic organs, whereas
pulmonary fibrosis
is a process of wound healing, which in part mimics the process of fetal lung development. We investigated the temporal and spatial changes in the distribution of
epimorphin
protein and expression of its messenger RNA (mRNA) in bleomycin-induced
pulmonary fibrosis
in mice. Immunohistochemical analysis showed that low levels of
epimorphin
were present in the bronchiolar, alveolar, and vascular walls of normal adult lungs. However, from Day 7 until Day 28 after bleomycin treatment, increasing levels of
epimorphin
immunoreactivity were detected in the mesenchymal cells and in the extracellular matrix within intra-alveolar fibrotic lesions. Moreover, Northern blots showed corresponding increases in
epimorphin
mRNA expression. Re-epithelialization of
epimorphin
-rich intra-alveolar fibrosis was complete by Day 28 after bleomycin, and by Day 56,
epimorphin
immunoreactivity had declined. In situ hybridization and confocal microscopic studies confirmed expression of
epimorphin
mRNA by mesenchymal cells situated within early fibrotic lesions, whereas immunoelectron microscopy localized the
epimorphin
to the endoplasmic reticulum of the mesenchymal cells and to the basement membrane and collagen fibrils in the area. These results suggest that
epimorphin
may contribute to the remodeling of
pulmonary fibrosis
via epithelial-mesenchymal interactions.
...
PMID:Increased expression of epimorphin in bleomycin-induced pulmonary fibrosis in mice. 1091 82
Epimorphin
modulates epithelial morphogenesis in embryonic mouse organs. We previously suggested that
epimorphin
contributes to repair of bleomycin-induced
pulmonary fibrosis
in mice via epithelium-mesenchyme interactions. To clarify the role of
epimorphin
in human lungs, we evaluated
epimorphin
expression and localization in normal lungs, lungs with nonspecific interstitial pneumonia (NSIP), and lungs with usual interstitial pneumonia (UIP); we also studied the effect of recombinant
epimorphin
on cultured human alveolar epithelial cells in vitro. Northern and Western blotting analyses revealed that
epimorphin
expression in NSIP samples were significantly higher than those in control lungs and lungs with UIP. Immunohistochemistry showed strong
epimorphin
expression in mesenchymal cells of early fibrotic lesions and localization of
epimorphin
protein on mesenchymal cells and extracellular matrix of early fibrotic lesions in the nonspecific interstitial pneumonia group. Double-labeled fluorescent images revealed expression of matrix metalloproteinase 2 in re-epithelialized cells overlying
epimorphin
-positive early fibrotic lesions. Immunohistochemistry and metalloproteinase activity assay demonstrated augmented expression of metalloproteinase induced by recombinant
epimorphin
in human alveolar epithelial cells. These findings suggest that
epimorphin
contributes to repair of
pulmonary fibrosis
in nonspecific interstitial pneumonia, perhaps partly by inducing expression of matrix metalloproteinase 2, which is an important proteolytic factor in lung remodeling.
...
PMID:Epimorphin expression in interstitial pneumonia. 1565 99